Phyton Biotech is the world's largest producer of taxane active pharmaceutical ingredients. The company produces Paclitaxel and Docetaxel through Plant Cell Fermentation (PCF(R)). These plant-derived products are used in the treatment of cancer and other life-threatening illnesses. Phyton was founded in 1990 in Ithaca, New York, and was acquired in 2003 by DFB Pharmaceuticals, a private Texas-based investment company. The company's manufacturing facilities are located in Ahrensburg, Germany and Delta, Canada.
Drugs in Development
KEY PRODUCTS
World’s Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
